1 METFORMIN HCL ER (METFORMIN HCL) | 40 of 410 | 1910 prescriptions Less than 1% of all prescriptions | 1500 | 440 patients 14% of all patients | < 11 | |
2 VICTOZA 3-PAK (LIRAGLUTIDE) | 10 of 340 | 1970 prescriptions Less than 1% of all prescriptions | 1580 | 420 patients 14% of all patients | 310 patients 10% of all patients | |
3 LEVOTHYROXINE SODIUM | 300 of 580 | 1670 prescriptions Less than 1% of all prescriptions | 1150 | 330 patients 11% of all patients | < 11 | |
4 SYNTHROID (LEVOTHYROXINE SODIUM) | 50 of 440 | 1820 prescriptions Less than 1% of all prescriptions | 1690 | 340 patients 11% of all patients | < 11 | |
5 ATORVASTATIN CALCIUM | 100 of 400 | 1300 prescriptions Less than 1% of all prescriptions | 1090 | 320 patients 10% of all patients | < 11 | |
6 METFORMIN HCL | 180 of 500 | 1170 prescriptions Less than 1% of all prescriptions | | 280 patients 9% of all patients | < 11 | |
7 TRULICITY (DULAGLUTIDE) | 10 of 320 | 1770 prescriptions Less than 1% of all prescriptions | 1620 | 290 patients 10% of all patients | < 11 | |
8 LANTUS SOLOSTAR (INSULIN GLARGINE,HUM.REC.ANLOG) | 160 of 480 | 1010 prescriptions Less than 1% of all prescriptions | | 290 patients 10% of all patients | < 11 | |
9 PIOGLITAZONE HCL | 20 of 230 | 820 prescriptions Less than 1% of all prescriptions | 820 | 150 patients 5% of all patients | 150 patients 5% of all patients | |
10 ULTRA-FINE NANO PEN NEEDLE (PEN NEEDLE, DIABETIC) | 20 of 360 | 760 prescriptions Less than 1% of all prescriptions | 550 | 280 patients 9% of all patients | < 11 | |
11 NOVOLOG FLEXPEN (INSULIN ASPART) | 40 of 410 | 1080 prescriptions Less than 1% of all prescriptions | 780 | 290 patients 10% of all patients | < 11 | |
12 LISINOPRIL | 150 of 390 | 500 prescriptions Less than 1% of all prescriptions | | 130 patients 4% of all patients | < 11 | |
13 ROSUVASTATIN CALCIUM | 60 of 230 | 500 prescriptions Less than 1% of all prescriptions | 340 | 120 patients 4% of all patients | < 11 | |
14 VICTOZA 2-PAK (LIRAGLUTIDE) | 10 of 160 | 920 prescriptions Less than 1% of all prescriptions | 470 | 210 patients 7% of all patients | < 11 | |
15 HUMALOG (INSULIN LISPRO) | 160 of 390 | 490 prescriptions Less than 1% of all prescriptions | 370 | < 11 | < 11 | |
16 LEVEMIR FLEXTOUCH (INSULIN DETEMIR) | 40 of 300 | 640 prescriptions Less than 1% of all prescriptions | 370 | 160 patients 5% of all patients | < 11 | |
17 INVOKANA (CANAGLIFLOZIN) | 60 of 150 | 510 prescriptions Less than 1% of all prescriptions | 510 | < 11 | < 11 | |
18 ULTRA-FINE MINI PEN NEEDLE (PEN NEEDLE, DIABETIC) | 30 of 300 | 370 prescriptions Less than 1% of all prescriptions | | 130 patients 4% of all patients | < 11 | |
19 HUMALOG KWIKPEN U-100 (INSULIN LISPRO) | 140 of 430 | 490 prescriptions Less than 1% of all prescriptions | | 120 patients 4% of all patients | < 11 | |
20 PRAVASTATIN SODIUM | 50 of 240 | 330 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
21 METHIMAZOLE | 260 of 510 | 430 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
22 SIMVASTATIN | 160 of 310 | 250 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
23 SPIRONOLACTONE | 60 of 140 | 220 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
24 JARDIANCE (EMPAGLIFLOZIN) | 160 of 260 | 280 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
25 HYDROCHLOROTHIAZIDE | 40 of 260 | 420 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
26 AMLODIPINE BESYLATE | 130 of 250 | 280 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
27 GLIMEPIRIDE | 250 of 380 | 330 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
28 NOVOLOG (INSULIN ASPART) | 230 of 380 | 320 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
29 CABERGOLINE | 10 of 150 | 380 prescriptions Less than 1% of all prescriptions | 380 | < 11 | < 11 | |
30 TRESIBA FLEXTOUCH U-200 (INSULIN DEGLUDEC) | 40 of 170 | 380 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
31 ULTRA-FINE SHORT PEN NEEDLE (PEN NEEDLE, DIABETIC) | 150 of 320 | 150 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
32 TOUJEO SOLOSTAR (INSULIN GLARGINE,HUM.REC.ANLOG) | 160 of 290 | 300 prescriptions Less than 1% of all prescriptions | 300 | < 11 | < 11 | |
33 CARVEDILOL | 30 of 100 | 260 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
34 HUMULIN R U-500 (INSULIN REGULAR, HUMAN) | 20 of 60 | 330 prescriptions Less than 1% of all prescriptions | 330 | < 11 | < 11 | |
35 TRADJENTA (LINAGLIPTIN) | 60 of 170 | 250 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
36 JANUVIA (SITAGLIPTIN PHOSPHATE) | 130 of 250 | 290 prescriptions Less than 1% of all prescriptions | 290 | < 11 | < 11 | |
37 RAMIPRIL | 30 of 100 | 260 prescriptions Less than 1% of all prescriptions | 260 | < 11 | < 11 | |
38 DULOXETINE HCL | 50 of 110 | 190 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
39 LOSARTAN-HYDROCHLOROTHIAZIDE (LOSARTAN/HYDROCHLOROTHIAZIDE) | 40 of 60 | 140 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
40 FENOFIBRATE (FENOFIBRATE,MICRONIZED) | 10 of 20 | 250 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
41 LOSARTAN POTASSIUM | 250 of 340 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
42 BASAGLAR KWIKPEN U-100 (INSULIN GLARGINE,HUM.REC.ANLOG) | 110 of 230 | 220 prescriptions Less than 1% of all prescriptions | 220 | < 11 | < 11 | |
43 JANUMET XR (SITAGLIPTIN PHOS/METFORMIN HCL) | 10 of 20 | 260 prescriptions Less than 1% of all prescriptions | 150 | < 11 | < 11 | |
44 ANDROGEL (TESTOSTERONE) | 40 of 70 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
45 GLIPIZIDE | 130 of 250 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
46 LIOTHYRONINE SODIUM | 230 of 300 | 200 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
47 FARXIGA (DAPAGLIFLOZIN PROPANEDIOL) | 30 of 110 | 230 prescriptions Less than 1% of all prescriptions | 230 | < 11 | < 11 | |
48 KOMBIGLYZE XR (SAXAGLIPTIN HCL/METFORMIN HCL) | 10 | 240 prescriptions Less than 1% of all prescriptions | 240 | < 11 | < 11 | |
49 CITALOPRAM HBR (CITALOPRAM HYDROBROMIDE) | 20 of 40 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
50 LEVOXYL (LEVOTHYROXINE SODIUM) | 90 of 150 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
51 EZETIMIBE | 160 of 200 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
52 FINASTERIDE | 20 of 30 | 130 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
53 METOPROLOL TARTRATE | 60 of 80 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
54 PREDNISONE | 150 of 180 | 110 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
55 CHLORTHALIDONE | 20 of 50 | 170 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
56 BYDUREON BCISE (EXENATIDE MICROSPHERES) | 20 of 70 | 200 prescriptions Less than 1% of all prescriptions | 200 | < 11 | < 11 | |
57 TIROSINT (LEVOTHYROXINE SODIUM) | 60 of 90 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
58 LANTUS (INSULIN GLARGINE,HUM.REC.ANLOG) | 350 of 410 | 160 prescriptions Less than 1% of all prescriptions | 160 | < 11 | < 11 | |
59 TRESIBA FLEXTOUCH U-100 (INSULIN DEGLUDEC) | 80 of 190 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
60 GABAPENTIN | 180 of 260 | 170 prescriptions Less than 1% of all prescriptions | 170 | < 11 | < 11 | |
61 ARMOUR THYROID (THYROID,PORK) | 60 of 80 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
62 AMLODIPINE-VALSARTAN-HCTZ (AMLODIPINE/VALSARTAN/HCTHIAZID) | 10 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
63 ONGLYZA (SAXAGLIPTIN HCL) | 10 of 20 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
64 V-GO 40 (SUB-Q INSULIN DEVICE, 40 UNIT) | 10 | 110 prescriptions Less than 1% of all prescriptions | 00 | < 11 | 00 patients Less than 1% of all patients | |